BBIO logo

BridgeBio Pharma (BBIO) CAPEX

annual CAPEX:

$8.91M+$7.60M(+582.08%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BBIO annual capital expenditures is $8.91 million, with the most recent change of +$7.60 million (+582.08%) on December 31, 2024.
  • During the last 3 years, BBIO annual CAPEX has fallen by -$39.34 million (-81.54%).
  • BBIO annual CAPEX is now -81.54% below its all-time high of $48.25 million, reached on December 31, 2021.

Performance

BBIO CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOcash flow metrics

quarterly CAPEX:

$1.59M-$1.64M(-50.73%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BBIO quarterly capital expenditures is $1.59 million, with the most recent change of -$1.64 million (-50.73%) on March 31, 2025.
  • Over the past year, BBIO quarterly CAPEX has increased by +$103.00 thousand (+6.90%).
  • BBIO quarterly CAPEX is now -96.15% below its all-time high of $41.46 million, reached on September 30, 2021.

Performance

BBIO quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOcash flow metrics

TTM CAPEX:

$9.01M+$103.00K(+1.16%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BBIO TTM capital expenditures is $9.01 million, with the most recent change of +$103.00 thousand (+1.16%) on March 31, 2025.
  • Over the past year, BBIO TTM CAPEX has increased by +$6.22 million (+223.44%).
  • BBIO TTM CAPEX is now -81.52% below its all-time high of $48.76 million, reached on June 30, 2022.

Performance

BBIO TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOcash flow metrics

BBIO CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+582.1%+6.9%+223.4%
3 y3 years-81.5%+85.7%-80.9%
5 y5 years+237.7%-64.4%+119.5%

BBIO CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-81.5%+582.1%-59.1%>+9999.0%-81.5%+590.0%
5 y5-year-81.5%+582.1%-96.2%>+9999.0%-81.5%+590.0%
alltimeall time-81.5%+582.1%-96.2%+311.8%-81.5%+2522.3%

BBIO CAPEX History

DateAnnualQuarterlyTTM
Mar 2025
-
$1.59M(-50.7%)
$9.01M(+1.2%)
Dec 2024
$8.91M(+582.1%)
$3.24M(+86.9%)
$8.91M(+45.9%)
Sep 2024
-
$1.73M(-29.2%)
$6.11M(+27.1%)
Jun 2024
-
$2.45M(+64.0%)
$4.80M(+72.5%)
Mar 2024
-
$1.49M(+243.0%)
$2.79M(+113.3%)
Dec 2023
$1.31M(-79.3%)
$435.00K(+0.9%)
$1.31M(-21.9%)
Sep 2023
-
$431.00K(+0.7%)
$1.67M(-16.4%)
Jun 2023
-
$428.00K(+3466.7%)
$2.00M(-63.5%)
Mar 2023
-
$12.00K(-98.5%)
$5.47M(-13.4%)
Dec 2022
$6.32M
$801.00K(+5.5%)
$6.32M(-21.5%)
Sep 2022
-
$759.00K(-80.5%)
$8.06M(-83.5%)
DateAnnualQuarterlyTTM
Jun 2022
-
$3.90M(+354.2%)
$48.76M(+3.4%)
Mar 2022
-
$859.00K(-66.1%)
$47.14M(-2.3%)
Dec 2021
$48.25M(+541.7%)
$2.54M(-93.9%)
$48.25M(+0.8%)
Sep 2021
-
$41.46M(+1712.9%)
$47.86M(+589.3%)
Jun 2021
-
$2.29M(+16.6%)
$6.94M(+38.8%)
Mar 2021
-
$1.96M(-8.6%)
$5.00M(-33.5%)
Dec 2020
$7.52M(+185.0%)
$2.15M(+290.9%)
$7.52M(+62.8%)
Sep 2020
-
$549.00K(+58.7%)
$4.62M(+3.8%)
Jun 2020
-
$346.00K(-92.3%)
$4.45M(+8.4%)
Mar 2020
-
$4.48M(-694.6%)
$4.11M(-1203.5%)
Dec 2019
$2.64M
-$753.00K(-297.6%)
-$372.00K(-197.6%)
Sep 2019
-
$381.00K
$381.00K

FAQ

  • What is BridgeBio Pharma annual capital expenditures?
  • What is the all time high annual CAPEX for BridgeBio Pharma?
  • What is BridgeBio Pharma annual CAPEX year-on-year change?
  • What is BridgeBio Pharma quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for BridgeBio Pharma?
  • What is BridgeBio Pharma quarterly CAPEX year-on-year change?
  • What is BridgeBio Pharma TTM capital expenditures?
  • What is the all time high TTM CAPEX for BridgeBio Pharma?
  • What is BridgeBio Pharma TTM CAPEX year-on-year change?

What is BridgeBio Pharma annual capital expenditures?

The current annual CAPEX of BBIO is $8.91M

What is the all time high annual CAPEX for BridgeBio Pharma?

BridgeBio Pharma all-time high annual capital expenditures is $48.25M

What is BridgeBio Pharma annual CAPEX year-on-year change?

Over the past year, BBIO annual capital expenditures has changed by +$7.60M (+582.08%)

What is BridgeBio Pharma quarterly capital expenditures?

The current quarterly CAPEX of BBIO is $1.59M

What is the all time high quarterly CAPEX for BridgeBio Pharma?

BridgeBio Pharma all-time high quarterly capital expenditures is $41.46M

What is BridgeBio Pharma quarterly CAPEX year-on-year change?

Over the past year, BBIO quarterly capital expenditures has changed by +$103.00K (+6.90%)

What is BridgeBio Pharma TTM capital expenditures?

The current TTM CAPEX of BBIO is $9.01M

What is the all time high TTM CAPEX for BridgeBio Pharma?

BridgeBio Pharma all-time high TTM capital expenditures is $48.76M

What is BridgeBio Pharma TTM CAPEX year-on-year change?

Over the past year, BBIO TTM capital expenditures has changed by +$6.22M (+223.44%)
On this page